11 – 20 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
(
- Contribution to journal › Article
- 2014
-
Mark
Analysis of Alpha-Synuclein in Malignant Melanoma - Development of a SRM Quantification Assay.
(
- Contribution to journal › Article
-
Mark
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
(
- Contribution to journal › Article
-
Mark
Molecular and genetic diversity in the metastatic process of melanoma.
(
- Contribution to journal › Article
-
Mark
Feasibility Study on Measuring Selected Proteins in Malignant Melanoma Tissue by SRM Quantification.
(
- Contribution to journal › Article
- 2012
-
Mark
Molecular profiling reveals low- and high-grade forms of primary melanoma
(
- Contribution to journal › Article
- 2010
-
Mark
Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
(
- Contribution to journal › Article
-
Mark
Analysis of protein expression in pure cell nuclei populations isolated from human breast cancer tissue by DNA flow cytometric sorting.
(
- Contribution to journal › Article
- 2008
-
Mark
a multicentre, phase ii study of cp-4055 in combination with sorafenib in patients with metastatic malignant melanoma
(
- Contribution to journal › Published meeting abstract
-
Mark
Overall Survival (OS) and New Patterns of Response in Patients (Pts) With Advanced Melanoma Treated With Ipilimumab
2008) 23rd Annual Meeting of the International-Society-for-Biological-Therapy-of-Cancer In Journal of Immunotherapy 31(9). p.937-938(
- Contribution to journal › Published meeting abstract